MedTrace Logo

An Evaluation of the WHO QUAlityRights Program

NCT06874439 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1800

Last updated 2025-12-04

No results posted yet for this study

Summary

The World Health Organization's (WHO) QualityRights (QR) program offers assessments and recommendations to help mental health facilities, on a voluntary basis, improve their care practices towards better respect of the rights of service users. The aim of this study is to evaluate the QR program in a French national context.

The main questions it aims to answer are:

* Does the QR program improve perceived satisfaction with care among mental health service users?
* What are the implementation procedures of the program?
* What is its budgetary impact?

Researchers will compare the QR program intervention with usual practices.

Conditions

  • Recovery
  • Organization of Health Service
  • Mental Health Care
  • Mental Health Services

Interventions

OTHER

WHO QualityRights program

The WHO's QualityRights program involves an assessment, called observation, of mental health care services by an ephemeral multidisciplinary team, which provides feedback and recommendations for improving care practices. The observation team, trained in the QualityRights (QR) methodology, includes mental health professionals, researchers, legal experts, and management staff from mental health organizations. Each team always incorporates at least one expert by experience and one informal caregiver or family member. Participation in the program is voluntary and initiated at the request of healthcare facilities. The observation is structured into three stages: 1. Site preparation 2. On-site observation 3. Restitution of observation report and follow-up

Sponsors & Collaborators

  • INSERM ECEVE 1123

    collaborator UNKNOWN

  • L'Assistance Publique - Hopitaux de Paris (AP-HP)

    collaborator UNKNOWN

  • GCS-CCOMS

    lead OTHER

Principal Investigators

  • Déborah Sebbane, MD, PhD · GCS-CCOMS & ECEVE 1123 INSERM

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-17
Primary Completion
2027-06-30
Completion
2027-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06874439 on ClinicalTrials.gov